Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $411M (100.0% shares, 0.0% debt)

Holdings (27)

SAGE THERAPEUTICS INC 10.0%
Value $41.18M Shares 250,000 Est. Cost $52.53 Unrealized
FOUNDATION MEDICINE INC 8.6%
Value $35.46M Shares 520,000 Est. Cost $22.74 Unrealized
LOXO ONCOLOGY INC 7.4%
Value $30.3M Shares 360,000 Est. Cost $28.44 Unrealized
BLUEPRINT MEDICINES CORP 6.4%
Value $26.24M Shares 348,000 Est. Cost $37.87 Unrealized
BLUEBIRD BIO INC 6.3%
Value $25.82M Shares 145,000 Est. Cost $115.06 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 6.2%
Value $25.41M Shares 200,000 Est. Cost $73.35 Unrealized +71.3%
MYOKARDIA INC 5.7%
Value $23.58M Shares 560,000 Est. Cost $22.11 Unrealized
SGMO SANGAMO THERAPEUTICS INC 5.6%
Value $22.96M Shares 1,400,000 Est. Cost $4.96 Unrealized +200.2%
GLOBAL BLOOD THERAPEUTICS IN 4.9%
Value $20.27M Shares 515,000 Est. Cost $29.83 Unrealized
VYGR VOYAGER THERAPEUTICS INC 4.6%
Value $18.84M Shares 1,135,000 Est. Cost $14.86 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 4.1%
Value $16.86M Shares 295,000 Est. Cost $53.23 Unrealized +18.2%
FATE FATE THERAPEUTICS INC 3.9%
Value $15.89M Shares 2,600,000 Est. Cost $4.33 Unrealized +3.1%
SPARK THERAPEUTICS INC 3.8%
Value $15.55M Shares 302,474 Est. Cost $54.57 Unrealized
CDXS CODEXIS INC 3.3%
Value $13.36M Shares 1,600,000 Est. Cost $4.93 Unrealized +40.4%
EVH EVOLENT HEALTH INC 3.2%
Value $13.25M Shares 1,077,500 Est. Cost $17.68 Unrealized -20.3%
AUDENTES THERAPEUTICS INC 3.0%
Value $12.5M Shares 400,000 Est. Cost $17.77 Unrealized
GENMARK DIAGNOSTICS INC 2.8%
Value $11.38M Shares 2,730,000 Est. Cost $7.42 Unrealized
ILMN ILLUMINA INC 2.3%
Value $9.614M Shares 44,000 Est. Cost $176.76 Unrealized +16.4%
CLOVIS ONCOLOGY INC 2.1%
Value $8.67M Shares 127,500 Est. Cost $88.33 Unrealized
JOUNCE THERAPEUTICS INC 1.5%
Value $6.056M Shares 475,000 Est. Cost $16.79 Unrealized
EDIT EDITAS MEDICINE INC 1.0%
Value $4.097M Shares 133,333 Est. Cost $20.61 Unrealized +22.2%
CTMX CYTOMX THERAPEUTICS INC 0.9%
Value $3.747M Shares 177,500 Est. Cost $15.07 Unrealized +37.6%
SYROS PHARMACEUTICALS INC 0.6%
Value $2.667M Shares 274,074 Est. Cost $13.79 Unrealized
GILD GILEAD SCIENCES INC 0.5%
Value $2.149M Shares 30,000 Est. Cost $55.90 Unrealized 0.0%
ONC BEIGENE LTD 0.4%
Value $1.759M Shares 18,000 Est. Cost $97.72 Unrealized
OVID OVID THERAPEUTICS INC 0.4%
Value $1.579M Shares 160,000 Est. Cost $13.06 Unrealized -29.7%
AGIO AGIOS PHARMACEUTICALS INC 0.3%
Value $1.429M Shares 25,000 Est. Cost $53.23 Unrealized +18.2%